-
Jazz Pharmaceuticals (NASDAQ:JAZZ) Receives "Overweight" Rating from Piper Sandler
Source: Buzz FX / 27 Feb 2025 13:46:20 America/New_York
Jazz Pharmaceuticals (NASDAQ:JAZZ) Receives "Overweight" Rating from Piper Sandler Written by MarketBeat February 27, 2025 Share Link copied to clipboard. Jazz Pharmaceuticals ( NASDAQ:JAZZ - Get Free Report ) 's stock had its "overweight"
Read more...